Key result
Postmortem peripheral blood troponin I identifies sudden cardiac death with ~0.76 diagnostic accuracy.
Why the study?
Differential diagnosis of sudden cardiac death remains challenging without evident structural abnormalities, and traditional forensic approaches rely on invasive pericardial fluid sampling rather than peripheral blood while facing concerns regarding marker stability.
Does postmortem peripheral blood cardiac biomarker analysis improve the diagnosis of sudden cardiac death in autopsied cadavers?
Case-Control (n=42)
No
Does postmortem peripheral blood cardiac biomarker analysis improve the diagnosis of sudden cardiac death in autopsied cadavers?
Postmortem peripheral blood Troponin I analysis using rapid immunofluorescence offers a practical and less invasive method to aid in the forensic diagnosis of sudden cardiac death.
BACKGROUND/OBJECTIVES: Differential diagnosis of sudden cardiac death (SCD) remains challenging, particularly in cases lacking evident structural abnormalities. Cardiac markers have been proposed as useful tools for this differentiation in forensic contexts. However, key issues include the influence of postmortem interval (PMI) on marker stability and the limitations of traditional approaches that focus on pericardial fluid, which requires invasive sampling compared to peripheral blood. This study aimed to evaluate the potential of cardiac markers in peripheral blood for diagnosing SCD, addressing methodological concerns related to PMI, hemolysis, and sample handling. METHODS: This study analyzed 5 cardiac markers (creatine kinase-MB [CK-MB], myoglobin, troponin I [TnI], BNP, and D-dimer) in peripheral blood samples from 42 autopsied cadavers, divided into an SCD group and a control group. Marker levels were quantified using immunofluorescence, with cases meticulously selected to exclude confounding factors such as chronic diseases, pulmonary thromboembolism, and drowning. The study also accounted for potential degradation due to PMI, and evaluated the accuracy of point-of-care testing (POCT) in forensic samples. RESULTS: The study identified statistically significant differences in myoglobin and TnI levels between the SCD group and the control group, though myoglobin's diagnostic reliability remains limited due to its lack of specificity for myocardial injury. TnI emerged as a more robust marker for SCD. Contrary to prior concerns, PMI showed no significant correlation with marker levels in samples handled without freeze-thaw cycles. Issues related to hemolysis were addressed, and no significant effects were observed from resuscitation maneuvers. CONCLUSIONS: This study supports the potential use of cardiac markers, particularly TnI, in peripheral blood for postmortem SCD diagnosis, emphasizing the importance of rapid and systematic analysis to minimize hemolysis-related variability. While further validation is needed to confirm these findings, this approach offers a less invasive, economical, and practical method for forensic investigations.
No takes yet. Share an insight, caveat, or question.
Sacco et al. (2025) conducted a case-control in Sudden cardiac death (SCD) (n=42). Postmortem peripheral blood Troponin I vs. Non-cardiac violent death controls was evaluated on Troponin I levels (AUC 0.76, p=0.002). Postmortem peripheral blood Troponin I levels were significantly higher in sudden cardiac death cases compared to controls (p=0.002), with an AUC of 0.76 for diagnostic accuracy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: